Alumni Ventures's Life Science Portfolio

Concerto Biosciences measures, maps, and utilizes microbes to create therapies and products for agriculture and human health industries.

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

Cambrian is a distributed development company building therapeutics to lengthen health span.

Uncommon is about providing with that juicy, tender, and delicious meat they love but without harming their health, planet, and animals.

Modicus Prime enables pharmaceutical manufacturers to deploy AI systems that are auditable and compliant by design.

Trilobio develops an automated laboratory platform that combines robotics, software, and tools to execute biological experiments.

Mapping interactions foundational to therapeutic discovery and human health.

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

Century Health accelerates drug development and commercialization by applying AI to real-world clinical data.

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.

Ossium Health builds a bone marrow bank to treat blood cancers.

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Biotechnology company developing combination therapeutics for cancer